On the contrary, TSPO deficiency increased the apoptotic rate of GL261 mouse glioma cells as measured by elevated basal caspase-3 activity, a phenotype which we also observed in TSPO-deficient BTICs [26]. This evidence concerns the gene TSPO and central nervous system cancer.